Cesare Gridelli, M.D.
S.G. Moscati Hopital, Avellino, Italy, Division of Medical Oncology
4
4
1
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Worked with same sponsors:
Ciro Gallo, M.D., Ph.D
Second University of Naples, Italy; Chair of Medical Statistics
Shared therapeutic areas:
Worked with same sponsors:
Massimo Di Maio, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Yongchang Zhang, MD
Hunan Cancer Hospital
Shared therapeutic areas:
Massimo Di Maio, M.D.
Giannettasio Hospital, Department of Oncology and Hematology
Shared therapeutic areas:
Worked with same sponsors:
Fortunato Ciardiello, M.D., Ph.D
Second Univesity of Naples, Italy; Chair Medical Oncology
Shared therapeutic areas:
Worked with same sponsors:
James C Yang, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
David R. Spigel, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Francois Benard, MD
BC Cancer
Shared therapeutic areas:
Anish Thomas, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer
CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer
STAD-1 Small Cell Lung Cancer Toxicity Adjusted Dosing Study
All 4 trials loaded